Real-World Study of Patients With EGFR Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Treated With First-Line Osimertinib

被引：0
|
作者：
Nieva, J. [1 ]
Taylor, A. [2 ]
Servidio, L. [3 ]
Sun, P. [2 ]
Okhuoya, P. [3 ]
Horvat, P. [4 ]
Tolani, E. [4 ]
Magee, K. [5 ]
Mathur, R. [5 ]
Balakrishna, S. [5 ]
机构：
[1] Univ Southern Calif, Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA
[2] Astrazeneca, Cambridge, England
[3] Astrazeneca, Gaithersburg, AL USA
[4] Iqvia, London, England
[5] Flatiron, New York, NY USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P48.17
引用
收藏
页码：S1113 / S1113
页数：1
相关论文
共 50 条
  • [1] First-line osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer
    Jeong, Byeong-Ho
    Um, Sang-Won
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (03)
  • [2] Real-World Experience of First-Line Osimertinib in EGFR Mutated Non-Small Cell Lung Cancers from a Tertiary Cancer Center, India
    Tiwari, Atul
    Singh, Ajay Kumar
    Noronha, Vanita
    Patil, Vijay M.
    Menon, Nandini
    Shah, Minit J.
    Shah, Darshit
    Jobanputra, Kunal
    Trikha, Mehak
    Ubharay, Ahmad
    Yadav, Shashikant
    Majumdar, Anuradha
    Chandrani, Pratik
    Kumar, Rajiv K.
    Pai, Trupti
    Janu, Amit
    Purandare, Nilendu
    Prabhash, Kumar
    SOUTH ASIAN JOURNAL OF CANCER, 2024,
  • [3] First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study
    Lorenzi, Martina
    Ferro, Alessandra
    Cecere, Fabiana
    Scattolin, Daniela
    Del Conte, Alessandro
    Follador, Alessandro
    Pilotto, Sara
    Polo, Valentina
    Santarpia, Mariacarmela
    Chiari, Rita
    Pavan, Alberto
    Dal Maso, Alessandro
    Da Ros, Valentina
    Targato, Giada
    Vari, Sabrina
    Indraccolo, Stefano
    Calabrese, Fiorella
    Frega, Stefano
    Bonanno, Laura
    Conte, Pier Franco
    Guarneri, Valentina
    Pasello, Giulia
    ONCOLOGIST, 2022, 27 (02): : 87 - E115
  • [4] Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer
    Liam, C.
    Ho, G.
    Chai, C.
    Alip, A. Bt
    Pang, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S998 - S999
  • [5] Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer
    Aguiar, Pedro N., Jr.
    Haaland, Benjamin
    Park, Wungki
    Tan, Pui San
    del Giglio, Auro
    Lopes, Gilberto de Lima, Jr.
    JAMA ONCOLOGY, 2018, 4 (08) : 1080 - 1084
  • [6] Treatment Patterns and Outcomes of First-line Osimertinib-treated Advanced EGFR Mutated NSCLC Patients: A Real-world Study
    Lee, J. Y.
    Mai, V.
    Garcia, M.
    Cheng, S.
    Khan, K.
    Balaratnam, K.
    Thakral, A.
    Brown, M. C.
    Zhan, L.
    Corke, L.
    Leighl, N.
    Shepherd, F. A.
    Bradbury, P.
    Sacher, A.
    Liu, G.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S440 - S440
  • [7] A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
    Cam Phuong Pham
    Thi Thai Hoa Nguyen
    Anh Tu Do
    Tuan Khoi Nguyen
    Thi Anh Thu Hoang
    Tuan Anh Le
    Dinh Thy Hao Vuong
    Dac Nhan Tam Nguyen
    Van Khiem Dang
    Thi Oanh Nguyen
    Van Luan Pham
    Minh Hai Nguyen
    Thi Huyen Trang Vo
    Hung Kien Do
    Ha Thanh Vu
    Thi Thuy Hang Nguyen
    Van Thai Pham
    Le Huy Trinh
    Khac Dung Nguyen
    Hoang Gia Nguyen
    Cong Minh Truong
    Tran Minh Chau Pham
    Thi Bich Phuong Nguyen
    BMC Cancer, 24
  • [8] A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
    Pham, Cam Phuong
    Nguyen, Thi Thai Hoa
    Do, Anh Tu
    Nguyen, Tuan Khoi
    Hoang, Thi Anh Thu
    Le, Tuan Anh
    Vuong, Dinh Thy Hao
    Nguyen, Dac Nhan Tam
    Dang, Van Khiem
    Nguyen, Thi Oanh
    Pham, Van Luan
    Nguyen, Minh Hai
    Vo, Thi Huyen Trang
    Do, Hung Kien
    Vu, Ha Thanh
    Nguyen, Thi Thuy Hang
    Pham, Van Thai
    Trinh, Le Huy
    Nguyen, Khac Dung
    Nguyen, Hoang Gia
    Truong, Cong Minh
    Pham, Tran Minh Chau
    Nguyen, Thi Bich Phuong
    BMC CANCER, 2024, 24 (01)
  • [9] Dacomitinib for the first-line treatment of patients with EGFR-mutated metastatic non-small cell lung cancer
    Santarpia, Mariacarmela
    Menis, Jessica
    Chaib, Imane
    Cao, Maria Gonzalez
    Rosell, Rafael
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (09) : 831 - 840
  • [10] Real-world study of dacomitinib as first-line treatment for patients with EGFR-mutant non-small cell lung cancer
    Shin, J. E.
    ANNALS OF ONCOLOGY, 2023, 34 : S1696 - S1697
12345